Security key
04390B105
ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (AAPG)
CUSIP: 04390B105
Q3 2026 13F Holders as of 30 Sep 2026
- Security type / class
- Equity / SPONSORED ADS
- Total 13F shares
- 5
- Total 13F value
- $83
- Share change
- +5
- SEC-reported price per share
- $16.60
- Number of holders
- 1
- Value change
- +$83
- Number of buys
- 1
Report period
Q3 2026
Institutions
1
Top holders
1
AAPG full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q2 2026
ASCENTAGE PHARMA GROUP INTERNATIONAL SEC filings
ASCENTAGE PHARMA GROUP INTERNATIONAL company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04390B105
Recent filing periods:
Ownership snapshot
Top reported holders of AAPG - ASCENTAGE PHARMA GROUP INTERNATIONAL - SPONSORED ADS (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Point72 Asset Management,...
Disclosed value leader
Point72 Asset Management,...
Comparable rows
0/15
Latest evidence
30 Jun 2026
13F
3/4/5
Highest disclosed value: $243,048
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Point72 Asset Management, L.P. has the largest disclosed position value at $243K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Point72 Asset Management, L.P.'s linked filing trail.
Disclosed position value
Top 5
Point72 Asset Management, L.P.
$243K
MORGAN STANLEY
$16.1K
WELLS FARGO & COMPANY/MN
$3.5K
EverSource Wealth Advisors, LLC
$421
UBS Group AG
$263
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. |
13F
Company
|
—
denominator unverified
|
$243,048
13,841 shares
|
— | 30 Jun 2026 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$16,138
919 shares
|
— | 30 Jun 2026 |
| WELLS FARGO & COMPANY/MN |
13F
Company
|
—
denominator unverified
|
$3,512
200 shares
|
— | 30 Jun 2026 |
| EverSource Wealth Advisors, LLC |
13F
Company
|
—
denominator unverified
|
$421
24 shares
|
— | 30 Jun 2026 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$263
15 shares
|
— | 30 Jun 2026 |
| BlackRock, Inc. |
13F
Company
|
—
denominator unverified
|
$105
6 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
5
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2026 vs Q2 2026 Across Filers
Q2 2026 holders
7
Q3 2026 holders
1
Holder diff
-6
| Investor | Q2 2026 Shares | Q3 2026 Shares | Share Diff | Share Chg % | Q2 2026 value | Q3 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend